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OXPHOS, and the pentose phosphate pathway (PPP) during murine norovirus infection. 23
Inhibiting glycolysis with 2-deoxyglucose (2DG) in transformed and primary macrophages 24 revealed that host cell metabolism is an important factor for optimal murine norovirus (MNV) 25 infection. 2DG affected an early stage in the viral life cycle after viral uptake and capsid 26 uncoating, leading to decreased levels of viral protein translation and viral RNA replication. The 27 requirement of central carbon metabolism was specific for MNV (but not astrovirus) infection, 28 independent of the Type I interferon antiviral response, and unlikely to be due to a lack of host 29 cell nucleotide synthesis. MNV infection increased activation of the protein kinase Akt, but not 30 AMPK, two master regulators of cellular metabolism, suggesting Akt signaling may play a role 31 in upregulating central carbon metabolism during norovirus infection. In conclusion, our findings 32 suggest that the metabolic state of target cells is an intrinsic host factor that determines the extent 33 of norovirus replication and implicates metabolism as a virulence determinant. They further 34 implicate cellular metabolism as a novel therapeutic target for norovirus infections and 35 improvements of current human norovirus culture systems. 36
INTRODUCTION 56
Viruses are obligate intracellular parasites. Thus, their biology is entirely dependent on 57 the physiology of the host cells they infect. One increasingly appreciated aspect of virus-host 58 interaction is cellular metabolism (1) (2) (3) (4) . Historically, cellular metabolism has been considered 59 mainly in terms of its role in cellular energy homeostasis. However, metabolism and metabolic 60 "cross talk" are increasingly being appreciated as crucial aspects in a range of cellular processes 61 such as proliferation and cell death (5), the activation and functioning of the immune system (6, 62 7), autophagy (8, 9) and in the establishment of infectious disease (10). Indeed, a wide range of 63 pathogens including parasites (11), bacteria (12-14) and viruses (3) have been shown to affect 64 and to be affected by their hosts' metabolic activity. Of note, the controlled modulation of 65 metabolism in immune cells has been shown to be a key feature in adaptive and innate immune 66 responses (6, (14) (15) (16) , and these findings have given rise to an entire field referred to as 67 "immunometabolism" (17) (18) (19) (20) . For example, macrophages adapt to a variety of metabolic 68 profiles depending upon the specific signals they sense (21, 22) . Specifically sensing through 69 different Toll-Like Receptors (TLR) in myeloid cells can initiate any combination of up-and/or 70 down-regulation of glycolysis and OXPHOS (23). Thus, metabolic processes are a vital feature 71 of the immune system for effectively combating viral infections, or an Achille's heel of the host 72 cell that can be manipulated by invading pathogens for their own advantage. 73
Eukaryotic cellular metabolism encompasses a wide range of catabolic and anabolic 74 processes, and various aspects of host metabolism have been linked to viral infections. In 75 particular, the major pathways of central carbon metabolism, glycolysis and oxidative 76 phosphorylation (OXPHOS), have been investigated for their role in viral infection. For 77 example, Kaposi's sarcoma herpesvirus (KSHV) suppresses aerobic glycolysis and OXPHOS to 78 foster cellular, and thus viral, survival (24) . In contrast, an array of diverse viruses such as herpes 79 simplex virus 1, HIV-1, rubella virus, white-spot syndrome virus, dengue virus, rhinovirus, 80 hepatitis C virus, influenza virus, and adenovirus (25-33) have been shown to initiate a host cell 81 response characterized by an increase in glycolysis, resulting in a more hospitable intracellular 82 environment for viral replication. However, the specific ways in which viral infections initiate 83 metabolic responses, and how these responses affect viral infection, vary substantially. 84
Disentangling the unique metabolic responses of host cells upon viral infection, especially in 85 regard to glycolysis and OXPHOS, may help in the development of broadly acting antiviral 86
therapies. 87
Human noroviruses (hNoV) are non-enveloped, positive-sense, single-stranded RNA 88 viruses of the Caliciviridae family that cause the majority of acute non-bacterial gastroenteritis 89 globally (34) (35) (36) (37) . In addition to the public health burden, the economic burden of hNoV 90 infections is enormous, with global costs estimated at $60 billion (US$) annually (35, 36) . 91
Currently, there are no licensed vaccines or antivirals that are effective against hNoV infections. 92
Although advances have been made in developing in vitro model systems for studying hNoV 93 (38) (39) (40) (41) (42) , the field still lacks a highly efficient, easy-to-use cell culture model. Therefore, murine 94 norovirus (MNV) remains a powerful tool for investigating general norovirus biology (43) (44) (45) . 95
The goal in the current study was to identify aspects of host cell metabolism that are important 96 for modulating MNV replication. Such findings may enable the development of more efficient 97 hNoV culture systems and/or antiviral therapies and vaccines for hNoV in the future (46). 98
With these goals in mind, we performed the first metabolomic analysis of norovirus 99 infection. Our analysis demonstrated that MNV infection of macrophages causes changes in the 100 host cell metabolic profile characterized by an increase in central carbon metabolism. Inhibition 101 of glycolysis with 2-deoxyglucose (2DG) severely attenuated MNV, but not human astrovirus 102 VA1, infection in vitro. Inhibition occurred at the level of replication, as we observed a lag in the 103 appearance of viral proteins in infected cells with a concomitant lag in viral genome replication, 104 but no effect on viral uptake or uncoating. Inhibition of MNV infection by 2DG was not rescued 105 by addition of nucleotides and was independent of Type I interferon responses. Investigations of 106 the two master regulators of cellular metabolism, Akt and AMPK, revealed that MNV infection 107 caused an increase in Akt activation, while inhibition of Akt signaling reduced both cellular 108 glycolysis and MNV infection. Overall, our findings identify central carbon metabolism as an 109 intrinsic host factor important for optimal MNV infection of macrophages. Since noroviruses 110 have a tropism for immune cells (47) (1, 3) . In our efforts to identify host cell factors that are important for successful 119 norovirus (NoV) infection, we hypothesized that infection of macrophages with murine 120 norovirus (MNV) causes changes in central carbon metabolism of host cells that are beneficial or 121 required for optimal viral infection. MNV-1 (CW3 isolate) is an acute strain of murine norovirus 122 that has a natural tropism for macrophages in vivo and is particularly efficient at infecting 123 transformed murine macrophages RAW 264.7 (RAW) (44). Thus, we performed a targeted 124 metabolomics profiling of MNV-infected RAW cells to identify changes in the amount of host 125 cell metabolites from glycolysis, the tricarboxylic acid cycle (TCA) and others. 126 A targeted mass spec analysis of metabolites isolated from MNV-1 infected RAW cells 127 (MOI=5) after eight hours of infection (approximately one replication cycle) revealed multiple 128 metabolites that were significantly increased in infected cells compared to mock cells, or 129 unchanged, but no metabolites that were significantly decreased during infection ( Fig. 1 ) 130 (Supplemental Tables 1 and 2). In particular, an increase in select metabolites from glycolysis 131 (fructose-bisphosphate, 2-and 3-phosphoglycerate, dihydroxyacetone-phosphate), the pentose 132 phosphate pathway (PPP) (6-phosphogluconate) and the TCA cycle (citrate/isocitrate, malate) 133 suggest that both energy generating pathways of glycolysis and oxidative phosphorylation are 134 increased during MNV infection ( Fig. 1A) . Notably, overall levels of ATP were higher in 135 infected cells compared to mock ( Fig. 1A) , indicating an overall increase in RAW cell 136 metabolism as a result of viral infection. The detection of a significant increase in metabolites in 137 cell culture is particularly noteworthy, since MNV-infected cultures represent a heterogeneous 138 population of infected and uninfected cells, since not all cells get infected by MNV even when 139 experiments are done with a high MOI (50). 140
Another group of metabolites that increased in RAW cells during MNV infection include 141 inosine-monophosphate (IMP), hypoxanthine and xanthine (Fig. 1B) . These metabolites are part 142 of a pathway involved in adenosine catabolism that can result in the production of uric acid, a 143 potent immune signal (16), and potentially reactive oxygen intermediates, which can have 144 signaling and antimicrobial activity. Upregulation of enzymatic activity in this pathway and an 145 increase in the resulting metabolites has been observed in the liver of mice infected with several 146 RNA and DNA viruses (51), in the lungs and tissues of influenza virus-infected mice (52), and in 147 mice infected with rhinovirus (53), and thus may represent a generalized cellular response to 148 viral infection. 149
Lastly, the metabolites uridine tri-phosphate (UTP), UDP-glucose, and UDP-D-150 glucuronate were also increased in MNV-infected RAW cells (Fig. 1C) . These metabolites are 151 part of the glucuronic acid pathway that can lead to the generation of proteoglycans and other 152 glycosylated forms of proteins (54) that have variable roles, including as potential extracellular 153 signals (55, 56) . Indeed, many hNoV strains, including the clinically relevant genogroup II, 154 genotype 4 viruses, are able to bind to host extracellular glycans, i.e., histo-blood group antigens 155 (57, 58) . Collectively, our metabolomics survey suggests that macrophages respond to MNV 156 infection by increasing: (i) the energy-and metabolite-generating pathways glycolysis and 157 oxidative phosphorylation; (ii) adenosine catabolism, which may be a part of the general innate 158 immune response; and, (iii) the glucuronic acid pathway, which may have effects on cellular 159 protein glycosylation. 160 161
2DG reduces MNV-1 infection in RAW cells and bone marrow-derived macrophages. 162
Metabolomics profiling of MNV infected RAW cells suggested that glycolysis and 163 OXPHOS are increased during viral infection. But whether this increase creates an intracellular 164 environment more supportive for viral replication, or rather represents an anti-viral immune 165 strategy of the host cell, is unclear from such a survey. To test whether host cell glycolysis is 166 supportive for effective MNV infection of macrophages in generating building blocks, viral 167 infection was measured in vitro in the presence of the potent and commonly used glycolysis 168 inhibitor 2-Deoxyglucose (2DG), a glucose analog that blocks early glycolysis (59, 60). 169 RAW cells were infected with MNV-1 at an MOI of five for one hour. Medium 170 containing 10 mM 2DG was then added post-infection to exclude direct effects of the compound 171 on virions. After an eight-hour incubation (one viral replication cycle), a greater than two log10 172 decrease in the number of infectious viral particles in 2DG-treated cells was observed by plaque 173 assay ( Fig. 2A) . RAW cells are a transformed cell line and generally engage in active "Warburg-174 effect" glycolysis (61). We therefore repeated the experiment in primary bone marrow-derived 175 macrophages (BMDM) isolated from Balb/c mice to determine whether glycolysis is also 176 relevant in non-transformed cells. 2DG treatment of BMDM caused an average one log10 177 decrease in viral loads after eight hours ( Fig. 2B) . 2DG treatment did not inhibit RAW viability 178 during an eight-hour treatment (Fig. 2C) , but did reduce RAW cell viability by about 30% after 179 24 hours ( Fig. S1A) . 180
Since RAW cells were grown in medium replete with glucose (~25 mM), putatively 181 creating a competitive metabolic situation between glucose and 2DG, we next determined the 182 minimal concentration of 2DG that significantly inhibited viral infection in RAW cells. Findings 183 from a dose-response study performed in the presence of glucose demonstrated that 2DG 184 inhibited MNV-1 infection in a dose-dependent manner with the lowest significant inhibition at 185 4.0 mM ( Fig. 2D) . 186
To determine the point during the infectious cycle that 2DG exerts its inhibitory effect on 187 MNV, a time-of-addition study was performed. RAW cells were infected with MNV-1 and 2DG 188 added to the medium at variable times post-infection. The results showed that 2DG had a 189 significant effect on MNV infection when added to the culture up to two hours post-infection 190 ( Fig. 2E ), suggesting that glycolysis is important for early steps in the viral life cycle. 191
These data are consistent with the notion that glycolysis is providing necessary building 192 blocks for viral replication. Thus, to determine whether 2DG might be exerting a generalized 193
anti-viral response in any transformed cell line against any virus, we tested viral infection of a 194 different ssRNA virus, human astrovirus VA1, which is readily propagated in Caco-2 cells (62). 195 Surprisingly, 2DG did not significantly inhibit human astrovirus infection in vitro (Fig. 2F) , 196
suggesting that the MNV phenotype in RAW cells and in BMDM is specific to MNV. 197 Taken together, these data demonstrate that host cell glycolysis, whether in primary or 198 transformed cells, contributes to optimal MNV infection in macrophages. They further suggest 199 that glycolysis is an intrinsic host factor that modulates infection in a virus-specific manner. 200
201

2DG treatment inhibits MNV-1 (-) strand vRNA and viral non-structural protein production. 202
Post-infection treatment of RAW cells with 2DG suggested that host cell glycolysis is 203 important for early stages of MNV infection ( Fig. 2E) . To more accurately pinpoint the stage in 204 the viral infectious cycle at which glycolysis is important, RAW cells were transfected directly 205 with viral RNA (vRNA) in order to bypass the steps of binding, uptake and virion uncoating. 206 2DG treatment of transfected RAW cells resulted in about a two log10 reduction of infectious 207 virus particle production after 12 hours (Fig. 3A) and a one log10 reduction at 24 hours ( Fig. S2) , 208 suggesting that 2DG does not affect virion binding or genome uncoating of MNV. 209 MNV is a single-stranded, positive (+) strand, non-enveloped virus, and so the viral life-210 cycle involves uptake of viral particles, uncoating of the (+) strand vRNA, direct translation of 211 the (+)-sense genome to produce the non-structural proteins (including the viral RNA 212 polymerase), followed by viral negative (-) RNA strand synthesis for eventual production of new 213 (+) strand vRNA, structural coat proteins, and progeny virion assembly ( Fig. 3B) . To measure 214 vRNA production during 2DG treatment, we isolated RNA over the course of a 12-hour 215 infection and assessed relative amounts of total and plus-and minus-strand vRNA (Figs. 3C, D, 216 and E) (63). At four hours post-infection (hpi), no difference in the quantity of (+) strand and 217 total vRNA was observed ( Figs. 3C and E) , indicating the same amount of virus infected the 218 cells, confirming 2DG has no significant effect on viral binding and entry. However, there is a 219 significant reduction in the amount of (-) strand vRNA at four hpi in 2DG-treated cells (Fig. 3D) . 220
At 8 and 12 hpi, there is significantly less vRNA overall for all species of RNA assessed ( Fig  221   3C-E) . These data demonstrated although vRNA replication occurs in 2DG-treated cells, a lag 222 occurred in transcription of (-) strand vRNA. 223
Since translation of the non-structural proteins precedes (-) strand vRNA synthesis, we 224 next assessed the quantity of MNV non-structural protein using anti-ProPol/NS6&7 and anti-225 capsid antibodies by Western blot during 2DG treatment. Cells treated with 2DG contained no 226 detectable Pol or VP1 proteins at 7 hpi, while reduced amounts of these proteins were present at 227 12 hpi (Fig. 3F) . These data indicate that host cell glycolysis is important for an early step in 228 viral replication after delivery of the viral RNA into the cytosol. 229
Taken together, inhibition of glycolysis with 2DG did not affect the ability of RAW cells 230 to internalize infectious virions, but it caused a delay in the translation of viral non-structural 231 proteins and negative-strand RNA synthesis. It is currently unclear whether the decrease in (-) 232 strand RNA levels are due to the reduced levels of viral non-structural proteins, including the 233 viral polymerase, or a direct inhibitory effect of 2DG on vRNA synthesis. 234 235
Inhibiting the pentose phosphate pathway reduces MNV infection of RAW cells 236
The metabolomics survey outlined in Figure 1 demonstrated that the first metabolite 237 produced from Glucose-6-phosphate in the oxidative half of the Pentose Phosphate Pathway 238 (PPP), 6-phosphogluconate, was more abundant in MNV-infected cells. This suggested that the 239 PPP, which branches off glycolysis at the early stage of glucose phosphorylation (64), may also 240 be important for MNV infection in RAW cells. Also, since 2DG interferes at the level of glucose 241 phosphorylation, the viral inhibition caused by 2DG may be due to interference with the PPP. 242 Therefore, to test the importance of the PPP for MNV infection, we used the inhibitor of 243 the PPP enzyme glucose-6-dehydrogenase, 6-Aminonicotinamide (6AN). Treatment with 500 244 M 6AN after MNV-1 infection caused a one log10 reduction in the production of infectious 245 MNV-1 after eight hours (Fig. 4A) . 6AN was non-toxic to RAW cells up to 1.0 mM during eight 246 hours (Fig. 4B) , whereas all concentrations of 6AN tested caused an approximately 30% 247 reduction in cell viability after 24 hours (Fig. S1B) . 248 Inhibition of MNV infection by 2DG may be partially due to its effect on the PPP by 249 depleting ribose nucleotides, one of the major end products of the PPP. Alphaviruses, which rely 250 on host cell glycolysis via PI3 kinase signaling, are partially rescued for viral replication with 251 ribose supplementation when PI3 kinase signaling is inhibited (65). Therefore, we infected RAW 252 cells with the minimal amount of 2DG that still causes a significant reduction in MNV infection 253 (4 mM), and supplemented the cultures with ribose alone (Fig. 4C) or pre-supplemented cells 254 with a mix of five ribonucleosides (Fig. 4D) . Neither treatment was sufficient to increase viral 255 titers during 2DG inhibition. These data suggest that, at least under the conditions tested, viral 256 inhibition from 2DG is caused by cellular changes other than nucleotide availability. 257
2DG viral inhibition is independent of the type I interferon response. 258
The mechanism of viral inhibition by 2DG could be due to a variety of cellular 259 perturbations that are caused by a decrease in glycolysis. MNV infection in RAW cells induces a 260 strong innate immune response, including interferon induction (66). Type I Interferons in turn 261 are able to affect host cell metabolism (67, 68), and exhibit a strong anti-MNV response (69-71). 262
Therefore, we determined whether 2DG inhibition of viral replication was dependent on type I 263 interferon responses. Wild-type C57BL/6 BMDM and BMDM lacking the type I interferon 264 receptor (IFNAR1 -/-) were infected with MNV-1 for one hour and then treated cells with 10 mM 265 2DG. After eight hours, both WT and IFNAR1-/-cells had reduced viral titers following 2DG 266 treatment compared to untreated cells (Fig. 5) . These data demonstrate that the inhibition of 267 MNV infection by 2DG is independent of the antiviral type I interferon response. 268
269
MNV-1 infection increases activation of Akt but not AMPK. 270
To identify cellular signaling pathways that underlie the observed metabolic changes 271 during MNV infection, we focused on two master regulators of metabolic control in cells, PI3-272 kinase/Akt and AMPK (72-80). In mammals, AMPK is able to sense the energetic status of cells, 273 specifically the ratio of AMP and ADP relative to ATP, and can promote fatty acid oxidation and 274 the expression of mitochondrial proteins (81-83). Western blot analysis of RAW cells revealed 275 very low levels of total AMPK protein, and no increases in phosphorylation at Thr172 between 276 mock-and virus-infected cells, or between untreated and 2DG-treated cells were observed ( Fig.  277   6A and Fig. S3 ). These data demonstrate that AMPK is not involved in the energetic changes in 278 RAW cells that we have observed during MNV infection. 279
Another protein that has been implicated in energy sensing in multiple cell types is Akt. 280
This kinase has been shown to play a key role in stimulating glycolysis and glucose metabolism 281 via multiple mechanisms (72, 76, 84) . In addition, Akt signaling is often altered during the 282 infectious cycle of numerous viruses (85). Western blot analysis of Akt activation during MNV-1 283 infection demonstrated that Akt phosphorylation at Ser473 was slightly elevated at 2 hpi (~2-284 fold) ( Fig. 6B and Fig. S3 ) above the baseline level of Akt activation in mock-treated RAW 285 cells. Akt was further activated as indicated by the higher level of Ser473 phosphorylation at 7 286 hpi (~10-fold higher) ( Fig. 6B) and 12 hpi (Fig. S4) . 2DG treatment prevented these increases in 287
Akt phosphorylation (Fig. 6B) . 288
Because Akt phosphorylation was elevated during MNV infection and 2DG blocked Akt 289 activation and viral replication, we asked whether inhibition of Akt signaling would inhibit MNV 290 infection in RAW cells, linking Akt signaling with a change in host cell glycolysis. Treating cells 291 with 15 M MK2206, a potent inhibitor of Akt phosphorylation, completely prevented Akt 292 phosphorylation at Ser473 (Fig. 6B) but did not affect AMPK phosphorylation (Fig. 6A) . 293
Treating RAW cells with 15 M MK2206 after the one hour MNV adsorption phase reduced 294 viral production after eight hours by about one log10 (Fig. 6C) . Furthermore, 2DG and MK2206 295 reduced RAW cell glycolysis irrespective of infection as measured by assaying end-point lactate 296 production ( Fig. 6D) . Both compounds are non-toxic at these concentrations ( Fig. S1C and  297   S1D) . These experiments demonstrate that Akt activation is a feature of MNV infection of RAW 298 cells, and that Akt plays a role in maintaining glycolysis in these cells. Akt activation during 299 MNV infection is consistent with a previous transcriptomic study of monocytes transfected with 300 the non-structural protein NS1-2, which implicated NS1-2 in affecting PI3K-Akt signaling 301 pathways (86). Taken together, these data are consistent with a model whereby MNV infection 302 upregulates glycolysis via Akt signaling. 303
304
DISCUSSION 305
When viruses infect cells, they are entirely dependent on the intracellular landscape of 306 their hosts in order to replicate efficiently. Indeed the intracellular metabolic state of target cells 307 acts as an intrinsic host factor, and a variety of metabolic pathways are important for successful 308 viral infection (3). However, different viruses cause diverse metabolic effects in various cell 309 types, and the mechanisms of viral engagement with host metabolic processes vary greatly (24-310 32). Thus, defining the specific host cell metabolic features that are required for individual 311 viruses may reveal key host cell vulnerabilities that could be helpful for the future development 312 of effective and safe antiviral therapies (46). Noroviruses lack effective therapies. In this study, 313
we uncover central carbon metabolism as an intrinsic factor that is important for optimal 314 infection of macrophages by MNV at early points during replication, suggesting a potential new 315 anti-norovirus target. 316
Maintaining homeostasis of glucose metabolism in mammalian physiology is of 317 importance in virtually every tissue, and glycolysis and OXPHOS are considered to be "central" 318 carbon metabolism since they are a hub for multiple metabolic pathways, and their vital role in 319 energy homeostasis. Therefore, it is not surprising that some viruses have evolved to take 320 advantage of different aspects of these conserved pathways to their benefit. Interestingly, 321 glycolysis may be increased or decreased in response to viral infection, with similar beneficial 322 outcomes for the virus. For instance, dengue virus increases both glucose uptake and 323 transcription of the important enzyme hexokinase 2 (28), while herpes simplex type 1 activates 324 glycolysis by increasing transcription and activation of the enzyme phosphofructokinase-1 (PFK-325 1) (33), with both viruses relying on active glycolysis for optimal infection. On the other hand, 326
Kaposi's sarcoma-associated herpesvirus (KSHV) causes a suppression of both aerobic 327 glycolysis and OXPHOS in transformed cells under nutrient stress, which thereby inhibits cell 328 death and enhances viral survival in this model of the tumor microenvironment (24). Our 329 observation that astrovirus infection was not affected by the treatment of Caco-2 cells with 2DG 330 highlights that not all viruses require glycolysis in transformed cells, which generally conduct a 331 significant level of "Warburg Effect" glycolysis at baseline (61). Thus, it was notable that 2DG 332 inhibited MNV infection in non-transformed primary cells, highlighting the fact that carbon 333 metabolism has pro-viral functions during norovirus infection. These results illustrate that the 334 relationship of target cell metabolism to viral infection is cell type-specific and virus-specific. 335
Another notable aspect of the relationship between carbon metabolism and infection is 336 the finding that glycolysis may facilitate infection outside of a canonical, metabolic role. HIV-1 337 causes an increase in expression of hexokinase-1 (HK1) accompanied by a decrease in enzymatic 338 activity (87). Our findings with 2DG, which targets the enzymatic activity of hexokinase, points 339 to a metabolic, rather than non-metabolic, role for glycolysis during norovirus infection. 340
Specifically, glucose-6-phosphate (G6P), located at the intersection of glycolysis and PPP, is a 341 major hub for macrophage metabolic regulation of MNV infection given that inhibition of the 342 PPP also reduced viral infection. 343
One particular caveat of host cell metabolic profiling studies is the complexity of 344 metabolic responses that immune cells can adopt in response to various stimuli. This is of 345 particular relevance for macrophages. Although the M0/M1/M2 system of categorizing 346 macrophage metabolic states is a useful construct for generalizing inflammatory versus non-347 inflammatory activity, these cells establish a complex range of metabolic phenotypes (22, 88, 348 89) . For example, although the bacterial product LPS causes an increase in glycolysis and a 349 decrease in OXPHOS in human monocytes, a different bacterial product, Pam3CysSK4 (P3C), 350 causes both pathways to increase (23). Thus, two different bacterial products signaling through 351 different Toll-like receptors (TLRs) establish unique metabolic profiles. This finding emphasizes 352 that unique pathogens elicit complex host metabolic responses, and that the range of molecular 353 signals that immune cells are responding to in vivo may determine the susceptibility of cell types 354 to certain infections. The metabolomics survey in this study demonstrated that MNV infection, 355 like P3C treatment, elicits an increase in both glycolysis and OXPHOS, and ongoing work is 356 seeking to reveal the individual contributions of these two pathways to norovirus infection. In 357 addition, since macrophages are target cells of MNV in vivo (44, 90) , it is conceivable that their 358 metabolic status during infection influences the establishment of norovirus infection at the 359 cellular levels with potential influences on viral pathogenesis. However, future studies are 360 needed to test this. 361
Another important aspect of macrophage metabolism is how metabolic rewiring controls 362 functional outputs, such as microbial killing mechanisms and cytokine/chemokine production 363 (7), which in turn could indirectly affect viral infection. Akt has been implicated in regulating 364 reactive oxygen species (ROS) generation (75). Although MNV infection increased Akt 365 activation, we did not observe an increase in general ROS in RAW cells upon 2DG treatment 366 ( Fig. S5) . Furthermore, blocking glycolysis with 2DG did not cause a significant difference in 367 the production of the inflammatory cytokine TNF in 2DG-treated RAW cells during MNV 368 infection (Fig. S6) . Combined with the finding that the effect of 2DG is independent of type I 369 IFN signaling, these data suggest that the antiviral effect of 2DG is not mediated via immune 370 signaling. However, whether MNV affects general macrophage functions via Akt activation and 371 metabolic rewiring of these cells will need to be tested in future studies. 372
A general caveat to the use of pharmacologic inhibitors in biological systems is their 373 potential for inducing side effects. Although 2DG has been commonly used as a prototypical 374 glycolysis inhibitor (59, 60), it may also affect other aspects of cell behavior that can influence 375 infectivity. For example, 2DG has been shown to induce ROS-triggered autophagy via AMPK 376 (91). This pathway is unlikely to be involved in the antiviral activity of 2DG in our studies 377 considering the lack of ROS induction upon 2DG treatment in RAW cells (Fig. S5) , and the lack 378 of AMPK induction during infection. Another study showed that 2DG can be damaging for 379 certain viral infections via initiation of an ER stress response in mice (92). Similarly, 2DG 380 decreases porcine epidemic diarrhea virus infection in vitro via triggering the unfolded protein 381 response and reducing protein translation (93). Our work showed that 2DG inhibited MNV 382 infection early during the viral life cycle, affecting the translation of non-structural proteins and 383 the transcription of new viral genomes. However, the virus does eventually begin to replicate 384 genomes and produce viral proteins even in the presence of 2DG. Thus, the mechanism by which 385 2DG causes this lag in the MNV life cycle could be via a rapid cellular stress response, or a 386 decrease in specific metabolites, or a combination of the two, and additional studies are needed 387 to clarify the relative contribution of both. 388
Lastly, it should be noted that a variety of metabolites, including Ornithine, 3-Phospho-389 Serine, Creatinine among others, were also increased during MNV infection. While these 390 molecules could be important host factors for viral infection, they were not explored further here. 391
Such investigations and an extension of metabolic findings to human noroviruses are planned for 392 the future. Human norovirus has remained stubbornly intractable to robust cultivation in vitro. 393
Although there has been some success in infecting transformed B cells (40) and human intestinal 394 enteroids (94) with human norovirus, viral loads remain low and an infectious, passagable cell 395 culture-derived virus stock remains elusive (95). Identifying host cell factors such as metabolites 396 and specific metabolic activities may therefore aid in optimizing in vitro cultivation systems for 397 human noroviruses. 398
In conclusion, we have shown that central carbon metabolism in macrophages is an 399 intrinsic factor promoting optimal infection of a norovirus. Our data are consistent with a model 400 whereby MNV activates the protein kinase Akt to increase central carbon metabolism in 401 macrophages. The glycolysis inhibitor 2DG inhibits norovirus (but not astrovirus) infection, 402 independent of the type I IFN response by limiting non-structural protein translation and viral 403 RNA synthesis. These findings reveal cellular metabolism as a potential therapeutic target for 404 norovirus and suggest a new strategy for improving human norovirus culture systems. 405
MATERIALS AND METHODS 406
Detailed methods can be found in Text S1 in the supplemental material. 407
Compounds and reagents: Please refer to Text S1 in the supplemental material for details. 408 
